Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates

Mycoses

Volumn 47, Issue 11-12, 2004, Pages 455-464

  Tintelnot, Kathrin ^a   Lemmer, K ^a   Losert, H ^a   Schar G ^b   Polak, A ^c  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c NONE

Author keywords

Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; FT IR spectroscopy; Genotyping; Sequencing; Serotype AD

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; FLUCONAZOLE; FLUCYTOSINE; TACROLIMUS;

ADULT; AUSTRIA; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; ENDEMIC DISEASE; EPIDEMIOLOGICAL DATA; FEMALE; FUNGUS ISOLATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; GERMANY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYBRID; INFECTION RISK; INFRARED SPECTROSCOPY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEROTYPE; SEX RATIO; SWITZERLAND;

ADULT; AGED; AUSTRIA; CLUSTER ANALYSIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; DNA FINGERPRINTING; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; GERMANY; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SWITZERLAND;

CRYPTOCOCCUS NEOFORMANS VAR. GRUBII; FILOBASIDIELLA NEOFORMANS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 12344310977     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2004.01072.x     Document Type: Review

References (37)

1. Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120: 123-30.
2. Mitchell DH, Sorrell TC, Allworth AM et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-6.
3. Viviani MA, Swinne D, Kouzmanov A et al. Survey of cryptococcosis in Europe. The ECMM working group report [abstract WG-02]. Abstracts of the 6th Congress of the European Confederation of Medical Mycology, Barcelona 9-11 November 2000. Rev Iberoam Micol 2000; 17: S115.
4. Tintelnot K, Schär G. Polak A. Epidemiological data of cryptococcosis in Austria. Germany and Switzerland: part of the ECMM survey in Europe. Mycoses 2001; 44: 345-50.
5. Franzot SP, Fries BC, Cleare W, Casadevall A. Genetic relationship between Crytococcus neoformans var. neoformans strains of serotypes A and D. J Clin Microbiol 1998; 36: 2200-4.
6. Diaz MR. Boekhout T. Theelen B, Fell JW. Molecular sequence analyses of the intergenic spacer (IGS) associated with rDNA of the two varieties of the pathogenic yeast, Cryptococcus neoformans. System Appl Microbiol 2000; 23: 535-45.
7. Boekhout T, Theelen B, Diaz M et al. Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology 2001; 147: 891-907.
8. Kwon-Chung KJ. Boekhout T. Fell JW, Diaz M. Proposal to conserve the name Cryptococcus gattii against Cr. hondurianus and Cr. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 2002; 51: 804-6.
9. Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999; 37: 838-40.
10. Varma A, Swinne D, Staib F, Bennett JE, Kwon-Chung KJ. Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol 1995; 33: 1807-14.
11. Meyer W, Mitchell TG. Polymerase chain reaction fingerprinting in fungi using single primers specific to mini-satellites and simple repetitive DNA sequences: strain variation in Cryptococcus neoformans. Electrophoresis 1995; 16: 1648-56.
12. Viviani MA, Wen H, Roverselli A et al. Identification by polymerase chain reaction fingerprinting of Cryptococcus neoformans serotype AD. J Med Vet Mycol 1997; 35: 355-60.
13. Lemmer K, Naumann D, Raddatz B, Tintelnot K. Molecular typing of Cryptococcus neoformans by PCR fingerprinting in comparison to serotyping and Fourier Transform Infrared Spectroscopy used for phenotyping. Med Mycol 2004; 42: 135-147.
14. Sorrell TC, Chen SCA, Ruma P et al. Concordance of clinical and environmental isolates of Cryptococcus neoformans variety gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J Clin Microbiol 1996; 34: 1253-60.
15. Boekhout T, van Belkum A. Variability of karyotypes and RAPD types in genetically related strains of Cryptococcus neoformans. Curr Genet 1997; 32: 203-8.
16. Xu J, Luo G, Vilgalys RJ, Brandt ME, Mitchell TG. Multiple origins of hybrid strains of Cryptococcus neoformans with serotype AD. Microbiology 2002; 148: 203-12.
17. Imai T, Watanabe K, Tamura M et al. Geographic grouping of Cryptococcus neoformans var. gattii by random amplified polymorphic DNA fingerprinting patterns and ITS sequence divergence. Clin Lab 2000; 46: 345-54.
18. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium or separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15: 525-37.
19. Wedde M, Müller D, Tintelnot K, De Hoog GS, Stahl U. PCR-based identification of clinically relevant Pseudallescheria/Scedosporium strains. Med Mycol 1998; 36: 61-67.
20. Meyer W, Marszewska K, Amirmostofian M et al. Molecular typing of global isolates of Cryptococcus neoformans var. neoformans by polymerase chain reaction fingerprinting and randomly amplified polymorphic DNA - a pilot study to standardize techniques on which to base a detailed epidemiological survey. Electrophoresis 1999; 20: 1790-9.
21. White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds), PCR Protocols: A Guide to Methods and Applications. San Diego: Academic Press, 1990: 315-22.
22. Lemmer K, Losert H, Rickerts V et al. Molekularbiologische Identifizierung von Cunninghamella spec. Mycoses 2002; 45 (Suppl. 1): 31-6.
23. Tintelnot K, Haase G, Seibold M et al. Evaluation of phenotypic markers for selection and identification of Candida dubliniensis. J Clin Microbiol 2000; 38: 1599-608.
24. Polak A, Müller J. Epidemiologie der Aspergillose und Cryptococcose in Deutschland. Mycoses 1998; 41 (Suppl. 1): 86.
25. Husain S, Wagener MM, Singh N. Cryptococcus neoformans infection in organ transplant recipients: variables influencing clinical characteristics and outcome. Emerg Infect Dis 2001; 7: 375-81.
26. Rimek D, Haase G, Lück A, Casper J, Podbielski A. Meningitis durch Cryptococcus adeliensis bei einer Patientin mit akuter myeloischer Leukämie. Mycoses 2003; 46: 265.
27. Tortorano AM, Viviani MA, Rigoni AL, Cogliati M, Roverselli A, Pagano A. Prevalence of serotype D in Cryptococcus neoformans isolates from HIV positive and HIV negative patients in Italy. Mycoses 1997; 40: 297-302.
28. FIMUA Cryptococcosis Network European Confederation of Medical Mycology (ECMM). Prospective survey of Cryptococcosis: report from Italy. Med Mycol 2002; 40: 507-17.
29. Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin O. Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group. Clin Infect Dis 1996; 23: 91-6.
30. Kaben U, Westphal HJ, Zimmermann R, Dunker H. Cryptococcosis of the skin. Hautarzt 1989; 40: 31-33.
31. Cogliati M, Allaria M, Liberi G, Tortorano AM, Viviani MA. Sequence analysis and ploidy determination of Cryptococcus neoformans var. neoformans. J Mycol Med 2000; 10: 171-6.
32. Cogliati M, Esposto MC, Clarke DL, Wickes BL, Viviani MA. Origin of Cryptococcus neoformans var. neoformans diploid strains. J Clin Microbiol 2001; 39: 3889-94.
33. Ellis D, Marriott D, Hajjeh RA, Warnock D, Meyer W, Barton R. Epidemiology: surveillance of fungal infections. Med Mycol 2000; 38 (Suppl. 1): 173-82.
34. Grosse P, Tintelnot K, Söllner O, Schmitz B. Encephalomyelitis due to Cryptococcus neoformans var. gattii presenting as spinal tumour: case report and review of the literature. J Neurol Neurosurg Psychiatry 2001; 70: 113-6.
35. Kohl KH, Hof H, Schrettenbrunner A, Seeliger HPR, Kwon-Chung KJ. Cryptococcus neoformans var. gattii in Europe. Lancet 1985; 29: 1515.
36. Montagna MT, Viviani MA, Pulito A et al. Cryptococcus neoformans var. gattii in Italy. Note II. Environmental investigation related to an autochtonous clinical case in Apulia. J Mycol Med 1997; 7: 93-6.
37. Baró T, Torres-Rodríguez JM, Hermoso de Mendoza M, Morera Y, Alia C. First identification of autochthonous Cryptococcus neoformans var. gattii isolated from goats with predominantly severe pulmonary disease in Spain. J Clin Microbiol 1998; 36: 458-61.